Paediatric craniofacial fibrous dysplasia: the Hospital for Sick Children experience and treatment philosophy

A Fattah1, D Khechoyan, J H Phillips

  • 1The Hospital for Sick Children, Division of Plastic Surgery, Department of Surgery, University of Toronto, 5430-555 University Avenue, Toronto, ON M5G 1X8, Canada.

Insights

Craniofacial fibrous dysplasia treatment outcomes suggest complete resection or debulking after skeletal maturity lowers recurrence. Early surgery, especially debulking, is linked to higher recurrence rates in pediatric patients.

Area of Science:

  • Craniofacial surgery
  • Pediatric oncology
  • Developmental biology

Background:

  • Craniofacial fibrous dysplasia involves normal bone replacement by fibro-osseous tissue.
  • This benign anomaly requires careful management in pediatric patients.

Purpose of the Study:

  • To audit patient data at a tertiary pediatric center.
  • To report on established treatment protocols for craniofacial fibrous dysplasia.

Main Methods:

  • Retrospective chart review of patients treated between 1999 and 2010.
  • Analysis of 37 patient records with sufficient documentation.
  • Evaluation of surgical outcomes and recurrence rates based on treatment type and timing.

Main Results:

  • Nine out of 27 surgically treated patients experienced recurrence, primarily with debulking therapy.
  • Surgery after skeletal maturity showed a lower recurrence rate (1/7) compared to earlier interventions (8/16).
  • Complete resection, regardless of age, and debulking post-maturity demonstrated lower recurrence risks.

Conclusions:

  • Complete resection or debulking surgery after skeletal maturity may reduce recurrence rates for craniofacial fibrous dysplasia.
  • Early surgical intervention, particularly debulking, is associated with higher recurrence.
  • McCune-Albright syndrome patients might benefit from repeated debulking over complex resections.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Fractures: Bone Repair01:27

Fractures: Bone Repair

Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Sutures of the Skull01:22

Sutures of the Skull

The human skull is composed of several bones that come together to protect the brain and support the structures of the face. The junctions where these bones meet are called sutures.
Sutures are immobile joints between adjacent bones of the skull. The narrow gap between the bones is filled with dense, fibrous connective tissue that unites the bones. The long sutures located between the skull bones are not straight but instead follow irregular, tightly twisting paths. These twisting lines tightly...